Arich Enterprise Co Ltd

4173 · TWO · Healthcare / Pharmaceutical Retailers

17.75TWD-0.20 (-1.11%)

Price History

Full chart

Market Stats

Previous Close17.95

Open17.95

Day Range17.75 – 17.95

52-Week Range16.90 – 25.30

Volume34.04K

Market Cap1.30B

P/E (TTM)22.03

Forward P/E0.00

EPS0.79

Dividend Yield5.98%

Beta0.09

50-Day Avg17.37

200-Day Avg19.24

About

Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion for pharmaceutical products; warehousing and logistics, and processing services. The company provides distribution and logistics services, including assists manufacturers with bidding processes; inventory management, order processing, invoicing, goods delivery, collection, customer complaint handling, and provides integrated pharmaceutical distribution services. In addition, it offers activities, such as hospital tender and bidding; pharmaceutical pricing negotiations; cold chain, clinical trial drug, and controlled drugs management; information, and financial flow. Arich Enterprise Co., Ltd. was founded in 1969 and is based in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryPharmaceutical Retailers
CEOHung Wen-Chuan
Employees0
HeadquartersNo.880, Zhongzheng Road, New Taipei City, Taiwan, 235601, Taiwan
Websitehttps://www.arich.com.tw

Leadership

Hung Wen-ChuanGeneral Manager
Yi Wen LinCFO & Accounting Supervisor

Financials

Income Statement

Currency: TWD	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.20B	1.30B	1.11B	1.25B	945.66M	1.02B	1.14B	1.30B	1.55B
Growth (%)	-	+8.08%	-14.57%	+12.52%	-24.43%	+7.65%	+11.99%	+13.83%	+19.20%
Cost of Revenue	1.04B	1.08B	911.85M	1.03B	737.99M	811.25M	906.59M	1.04B	1.24B
Gross Profit	161.40M	221.39M	200.30M	216.96M	207.68M	206.77M	233.49M	252.94M	310.63M
Gross Margin	13.40%	17.01%	18.01%	17.34%	21.96%	20.31%	20.48%	19.49%	20.08%
Operating Expense	158.66M	174.43M	138.68M	151.56M	129.02M	122.17M	134.48M	157.85M	207.10M
Operating Income	2.74M	46.96M	61.62M	65.40M	78.66M	84.61M	99.01M	95.09M	103.52M
Operating Margin	0.23%	3.61%	5.54%	5.23%	8.32%	8.31%	8.68%	7.33%	6.69%
EBITDA	24.10M	67.67M	119.40M	100.12M	120.48M	127.35M	148.57M	164.16M	184.16M
EBITDA Margin	2.00%	5.20%	10.74%	8.00%	12.74%	12.51%	13.03%	12.65%	11.90%
Net Income	5.19M	50.28M	60.63M	47.25M	55.30M	62.62M	76.53M	93.86M	86.79M
Net Income Margin	0.43%	3.86%	5.45%	3.78%	5.85%	6.15%	6.71%	7.23%	5.61%
Interest Expense	0	15.97M	13.29M	6.56M	4.50M	3.38M	3.96M	6.34M	7.53M
Interest Expense % of Total Revenue	0.00%	1.23%	1.20%	0.52%	0.48%	0.33%	0.35%	0.49%	0.49%

Balance Sheet

Currency: TWD	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	5.33B	4.71B	3.76B	3.95B	4.49B	4.94B	5.62B	7.10B	5.26B
Total Liabilities	4.28B	3.50B	2.50B	2.17B	2.67B	3.06B	3.60B	5.18B	3.25B
Total Equity	1.05B	1.21B	1.26B	1.78B	1.82B	1.88B	2.02B	1.92B	2.01B
Cash	298.39M	80.22M	582.46M	411.44M	580.25M	690.73M	554.14M	2.23B	711.16M
Total Debt	-	-	-	283.89M	164.76M	64.48M	328.98M	-	-
Net Debt	851.61M	1.02B	-582.46M	-127.54M	-415.50M	-626.25M	-225.16M	-	-

Cash Flow

Currency: TWD	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-626.72M	-233.19M	564.44M	559.56M	336.06M	139.23M	-274.45M	2.15B	-1.90B
Investing Cash Flow	410.35M	93.94M	-40.17M	-47.87M	30.41M	-	-	-	-
Financing Cash Flow	231.12M	-78.93M	-436.95M	-267.79M	-197.67M	-77.51M	206.40M	-	-
Capital Expenditure	1.41M	304.00K	3.08M	5.48M	13.14M	22.38M	28.90M	6.36M	7.36M
Free Cash Flow	-629.51M	-250.82M	548.48M	554.08M	322.93M	116.85M	-303.35M	2.14B	-1.91B
Dividends Paid	23.88M	13.37M	46.29M	44.57M	41.78M	37.29M	48.47M	68.58M	88.61M
FCF to OCF	100.45%	107.56%	97.17%	99.02%	96.09%	83.93%	110.53%	99.70%	100.39%
Dividend Paid to FCF	-3.79%	-5.33%	8.44%	8.04%	12.94%	31.91%	-15.98%	3.20%	-4.64%

Earnings

Report Date	May 29, 2013	Aug 28, 2013	Nov 27, 2013	Feb 26, 2014	May 28, 2014	Sep 3, 2014	Dec 3, 2014	Feb 25, 2015	Jun 3, 2015	Sep 2, 2015	Dec 2, 2015	Mar 2, 2016	Jun 1, 2016	Aug 12, 2016	Nov 12, 2016	Mar 27, 2017	May 14, 2017	Aug 14, 2017	Nov 10, 2017	Mar 26, 2018	May 15, 2018	Aug 13, 2018	Nov 14, 2018	Mar 28, 2019	May 29, 2019	Aug 28, 2019	Nov 27, 2019	Feb 26, 2020	Jun 3, 2020	Sep 2, 2020	Dec 2, 2020	Mar 3, 2021	Jun 2, 2021	Sep 1, 2021	Dec 1, 2021	Mar 2, 2022	Jun 1, 2022	Aug 31, 2022	Nov 30, 2022	Mar 1, 2023	May 31, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.30	0.40	0.37	0.40	0.16	0.22	0.21	0.12	0.10	0.21	0.06	0.13	0.10	0.21	0.06	0.16	0.01	0.03	-0.06	0.12	0.31	0.24	0.31	0.16	0.36	0.45	0.24	0.28	0.33	0.30	0.06	0.09	0.15	0.13	0.12	0.33	0.16	0.27	0.23	0.18	0.23
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.30B

Enterprise Value845.72M

Trailing P/E22.03

Forward P/E0.00

Price / Sales0.83

Price / Book0.68

EPS0.79

Book Value25.35

Revenue (TTM)1.56B

Gross Profit (TTM)295.56M

EBITDA78.30M

Profit Margin3.81%

Operating Margin4.09%

Return on Equity3.12%

Return on Assets0.78%

Shares Outstanding74.57M

Shares Float44.71M

Beta0.09

Dividend Yield5.98%

Dividend Rate1.04

Payout Ratio131.65%

Dividends

20261×

1.04Apr 16, 2026

20251×

1.19Apr 17, 2025

20241×

0.92Apr 11, 2024

20231×

0.65Jul 11, 2023

20221×

0.50Jul 13, 2022

20211×

0.56Aug 2, 2021

20201×

0.60Aug 3, 2020

20191×

0.94Aug 22, 2019

20181×

0.27Aug 23, 2018

20171×

0.48Jul 31, 2017

20161×

0.27Jul 28, 2016

20151×

0.74Aug 17, 2015

20141×

1.05Jul 3, 2014

20131×

1.36Aug 16, 2013